Barchart.com
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)
9.30 x 1 9.66 x 1
Post-market by (Cboe BZX)
9.45 +0.14 (+1.50%) 04/24/25 [NASDAQ]
9.30 x 1 9.66 x 1
Post-market 9.31 -0.14 (-1.48%) 17:24 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board GlobeNewswire - Wed Apr 23, 6:30AM CDT

AVXL : 9.45 (+1.50%)
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East GlobeNewswire - Mon Apr 21, 6:30AM CDT

AVXL : 9.45 (+1.50%)
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease GlobeNewswire - Sat Apr 5, 10:30AM CDT

AVXL : 9.45 (+1.50%)
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference GlobeNewswire - Mon Mar 31, 6:30AM CDT

AVXL : 9.45 (+1.50%)
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference GlobeNewswire - Mon Feb 24, 6:30AM CST

AVXL : 9.45 (+1.50%)
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot AP - Wed Feb 12, 6:39AM CST

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

AVXL : 9.45 (+1.50%)
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update GlobeNewswire - Wed Feb 12, 6:30AM CST

AVXL : 9.45 (+1.50%)
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025 GlobeNewswire - Wed Feb 5, 6:30AM CST

AVXL : 9.45 (+1.50%)
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio GlobeNewswire - Mon Jan 27, 6:30AM CST

AVXL : 9.45 (+1.50%)
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease GlobeNewswire - Wed Jan 15, 6:30AM CST

AVXL : 9.45 (+1.50%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 1 hour ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot